ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.45 Cr | ₹25 Cr | ₹20 Cr | ₹29 Cr | ₹33 Cr |
What is the latest Contingent Liabilities ratio of ANUH PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹7.45 Cr |
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹33 Cr |
How is Contingent Liabilities of ANUH PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.45 Cr | -70.49 | |
| Mar2025 | ₹25 Cr | 24.50 | |
| Mar2024 | ₹20 Cr | -30.61 | |
| Mar2023 | ₹29 Cr | -11.19 | |
| Mar2022 | ₹33 Cr | - | |
Compare Contingent Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹801.6 Cr | 4% | -10.8% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 4% |
-10.8% |
-4% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses